SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001741830-20-000018
Filing Date
2020-11-18
Accepted
2020-11-18 08:05:00
Documents
89
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q kron-20200930.htm   iXBRL 10-Q 2072789
2 EX-10.1 kronq3fy2020ex101.htm EX-10.1 60203
3 EX-31.1 kronq3fy2020ex311.htm EX-31.1 18563
4 EX-31.2 kronq3fy2020ex312.htm EX-31.2 18188
5 EX-32.1 kronq3fy2020ex321.htm EX-32.1 11478
  Complete submission text file 0001741830-20-000018.txt   8937281

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kron-20200930.xsd EX-101.SCH 55561
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kron-20200930_cal.xml EX-101.CAL 95620
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kron-20200930_def.xml EX-101.DEF 282775
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kron-20200930_lab.xml EX-101.LAB 644368
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kron-20200930_pre.xml EX-101.PRE 464943
11 EXTRACTED XBRL INSTANCE DOCUMENT kron-20200930_htm.xml XML 1577003
Mailing Address 1300 S. EL CAMINO REAL SUITE 300 SAN MATEO CA 94402
Business Address 1300 S. EL CAMINO REAL SUITE 300 SAN MATEO CA 94402 212-871-7920
Kronos Bio, Inc. (Filer) CIK: 0001741830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39592 | Film No.: 201323013
SIC: 2834 Pharmaceutical Preparations